Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
certain assets from other companies
|
| gptkbp:CEO |
Dr. Shankar Musunuri
|
| gptkbp:clinicalTrials |
yes
|
| gptkbp:develops |
apoptosis-targeted therapies
|
| gptkbp:focusesOn |
cancer therapeutics
|
| gptkbp:founded |
2010
|
| gptkbp:headquarters |
gptkb:Boston,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aprea Therapeutics
|
| gptkbp:investmentFocus |
various venture capital firms
|
| gptkbp:partnerships |
various pharmaceutical companies
|
| gptkbp:publicTransport |
yes
|
| gptkbp:researchFocus |
p53 pathway
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:tributaryOf |
multiple drug candidates
|
| gptkbp:website |
www.apreatx.com
|